The June 2026 FDA approval of SKINVIVE by JUVÉDERM for horizontal neck lines gives aesthetic providers a new on-label option for an area that has historically relied on off-label approaches. Understanding where it fits — and where it doesn’t — is what separates confident treatment planning from guesswork.
The most qualified patient who walks into an aesthetic practice is usually one sent by another provider — someone who already trusts the recommendation before they call to book. Building those relationships requires deliberate outreach, not just doing good work and waiting.
Hair shedding is one of the most commonly reported but least-addressed sequelae of GLP-1-related weight loss, and it often overlaps with menopausal female pattern hair loss in the same patient. Aesthetic providers who can identify both presentations and offer structured interventions have a meaningful clinical and practice expansion opportunity.
IAPAM is offering July 4th pricing on both Safe Start training paths through July 8, 2026 — plus a free Introduction to Stem Cells and Exosomes course ($250 value) with every enrollment.
Obagi® saypha® ChIQ™ is the latest FDA-approved HA filler for cheek augmentation, but entry into a crowded midface filler market demands a rigorous evaluation framework. This article walks through the clinical questions every injector should ask before adding a new product.
Burnout in insurance-based medicine isn’t new — but what physicians are doing about it is changing. Providers from emergency medicine, urology, OB/GYN, family medicine, and beyond are adding aesthetic medicine as a cash-pay, patient-driven complement to their existing practice.
BMI alone misses many high-risk patients. OBSCORE, a new Nature Medicine tool validated in approximately 200,000 participants, gives medical weight management providers a more precise framework for prioritizing interventions.
Botox® resistance has identifiable triggers and formulation-level solutions. Here’s what aesthetic providers need to know about immunogenicity and management.
Medical weight management providers have already figured out that the real revenue expansion in GLP-1 programs comes from the body contouring services layered on after significant weight loss. Aesthetic providers — already equipped with the skills and tools to serve these patients — are only starting to catch on.
Setting prices for aesthetic treatments is different from billing insurance. Here’s a practical framework for benchmarking your market and building a fee structure that’s profitable.
Terms and conditions apply. Offer expires September 30.